Solventum
Preço: 78.87Empresa e modelo de negócios
Solventum operates in the healthcare sector, focusing on the development and commercialization of innovative medical solutions. Its core products include advanced therapeutic devices and diagnostic tools aimed at improving patient outcomes. The company generates revenue primarily through product sales and partnerships with healthcare providers and institutions. Solventum's business segments encompass research and development, manufacturing, and distribution of healthcare technologies.
Perfil de investimento
The investment profile of Solventum is more aligned with growth investors, given its focus on innovation and potential for revenue expansion. The company shows stable earnings growth and a moderate risk profile, appealing to those seeking capital appreciation. Its performance metrics suggest a favorable outlook for long-term investment strategies.
Métricas fundamentais (experimental)
- EPS (TTM) — lucro por ação dos últimos 12 meses, $
- 8.21 OK
- Receita QoQ — crescimento da receita trimestre contra trimestre
- 0.5% ≈
- Surpresa de EPS
- 9.6% melhor que o esperado
- Volatilidade 20d
- 2.1% estável
Impacto da previsão
esgotadoAcompanhar no portfólio
Gráfico de preço
| Data | Antes | Depois | Motivo |
|---|---|---|---|
| 2026-06-10 00:49 | Manter | Comprar | Strong momentum and positive EPS surprise indicate growth potential. |
| 2026-06-09 02:51 | Comprar | Manter | Mixed performance and uncertain market conditions. |
| 2026-06-05 02:48 | Manter | Comprar | Strong momentum and solid EPS growth support bullish outlook. |
| Data | Analista | Action | Alvo | Preço na época |
|---|---|---|---|---|
| 2026-06-01 11:15 | Jefferies | Preço-alvo elevado | — → 43 | 74.95 |
| 2026-05-15 11:13 | Wedbush | Atualizar | — → 94 | 74.42 |
| 2026-05-06 13:34 | UBS | Preço-alvo reduzido | 82 → 78 | 71.355 |
Nada ainda